Related Experiment Video
Updated: Jan 7, 2026

A New Single Chamber Implantable Defibrillator with Atrial Sensing: A Practical Demonstration of Sensing and Ease of Implantation
Published on: February 28, 2012
Streptococcus agalactiae Endocarditis Involving the Tricuspid Valve and Device Leads in a Patient With an Automated
Mehrdad Zarghami1, Anubhav Agarwal2, Alexandria Jaramillo2
1Internal Medicine, Jamaica Hospital Medical Center, New York City, USA.
Abstract:
Infective endocarditis involving cardiac device leads remains a serious complication in patients with intracardiac hardware, particularly in the setting of bacteremia. We present a case of a 47-year-old female with heart failure with reduced ejection fraction (HFrEF) and an automated implantable cardioverter-defibrillator (AICD) who developed Group B Streptococcus (Streptococcus agalactiae) bacteremia with evidence of both lead-associated and tricuspid valve vegetations. The case highlights diagnostic challenges in transthoracic echocardiography (TTE), multidisciplinary management, and the role of early device extraction in such cases.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Endocarditis II: Clinical Features of Infective Endocarditis
Mitral Stenosis III: Medical Management

